1. Home
  2. MYFW vs NKTX Comparison

MYFW vs NKTX Comparison

Compare MYFW & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MYFW

First Western Financial Inc.

HOLD

Current Price

$27.64

Market Cap

256.7M

Sector

Finance

ML Signal

HOLD

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.70

Market Cap

247.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYFW
NKTX
Founded
2002
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
256.7M
247.4M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
MYFW
NKTX
Price
$27.64
$2.70
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$26.50
$11.33
AVG Volume (30 Days)
20.7K
948.3K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
54.02
11.88
EPS
1.34
N/A
Revenue
$96,914,000.00
N/A
Revenue This Year
$20.48
N/A
Revenue Next Year
$9.70
N/A
P/E Ratio
$20.84
N/A
Revenue Growth
7.60
N/A
52 Week Low
$20.10
$1.63
52 Week High
$28.00
$3.65

Technical Indicators

Market Signals
Indicator
MYFW
NKTX
Relative Strength Index (RSI) 62.81 51.17
Support Level $22.04 $1.88
Resistance Level $28.00 $3.65
Average True Range (ATR) 0.67 0.27
MACD 0.13 -0.01
Stochastic Oscillator 77.12 36.51

Price Performance

Historical Comparison
MYFW
NKTX

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: